Syngenta expects ChemChina takeover will be approved by U.S. regulators by year end

Screen Shot at PM

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis.

Syngenta AG, which has agreed to be taken over by China National Chemical Corp. for $43 billion, said talks with regulatory authorities to win approval for the deal have been constructive and the Swiss company is confident the transaction can be closed on time.

Talks with the Committee on Foreign Investment in the U.S. [CFIUS] are ongoing and the goal remains to complete the deal by year end, Chief Executive Officer Erik Fyrwald said in a phone interview on [July 22]. . . .

. . . .

ChemChina is seeking regulatory approval for the purchase that will make it the worldโ€™s largest supplier of pesticides and other crop-care chemicals, albeit temporarily. Dow Chemical Co.โ€™s merger with DuPont Co. and Bayer AGโ€™s possible purchase of Monsanto Co. will reorder the rankings as the top six suppliers jostle for market share and financial power. . .

With Syngenta, investors are focused on the process of winning approval from CFIUS in a presidential election year. The regulator can recommend a deal be blocked for reasons of national security, and this time around the panel includes the USDAย as the planned acquisition involves food security. . . .

Read full, original post:ย Syngenta Says U.S. Talks Over ChemChina Bid โ€˜Constructiveโ€™

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosateโ€”the world's most heavily-used herbicideโ€”pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Screenshot-2026-05-01-at-1.29.41-PM
Viewpoint: What happens when whole grains meet modern food manufacturing? Labels donโ€™t tell the whole story.
Farmers can talk to plants
Farmers are a major source of misinformationโ€”about farming
ChatGPT-Image-Apr-13-2026-02_20_22-PM
Viewpoint: Misinformation infodemic? Why assessing evidence is so challengingย 
ChatGPT-Image-Mar-27-2026-11_47_30-AM-2
FDAโ€™s expedited drug reviews are hailed in some quarters but other approval practices are problematic
Screenshot-2026-04-12-135256
Bixonimania: The fake disease scam that AI swallowed whole
S
As vaccine rejectionism spreads, measles may be taking a more dangerous turn
bigstock opioids on chalkboard with rol
GLP podcast: 'Safe injection sites': enabling drug addiction or saving lives?

Sorry. No data so far.

glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.